Stemline Therapeutics Inc, based in New York, NY, is a biopharmaceutical company focused on the development and commercialization of innovative oncology therapeutics. With a robust product pipeline and a team of dedicated professionals, Stemline is committed to advancing novel treatments for patients with cancer, including those with rare and aggressive hematologic malignancies.
As part of the Menarini Group, Stemline Therapeutics combines scientific expertise with a patient-centric approach to deliver cutting-edge therapies. Through their clinical trials and expanded access programs, Stemline aims to provide hope and improved outcomes for individuals worldwide facing challenging cancer diagnoses.
Generated from the website